Studying the cell is a difficult and time-consuming process, but scientists have pinpointed generative AI as a potential way to make it easier. The idea is to develop an AI virtual cell that would ...

How difficult is it to make a cell type? How many of that cell type do you need? What’s the addressable market? These are the first questions that Brian Culley—CEO at Lineage Cell Therapeutics, a ...

ATPG targets faults at IC-gate boundaries, but 50% of defects are located within cells. Learn how cell-aware ATPG and user-defined fault models help to ferret out these hard-to-squash bugs.

“How difficult is it to make a cell type? How many of that cell type do you need? What’s the addressable market?” That’s the first line of questions that Brian Culley—CEO at Lineage Cell Therapeutics, ...